These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 12838934)

  • 41. Nothing can stent device's growth.
    Scott L
    Mod Healthc; 1996 May; 26(20):46. PubMed ID: 10157479
    [No Abstract]   [Full Text] [Related]  

  • 42. FDA marketing claims, and the practitioner.
    Runner S
    J Evid Based Dent Pract; 2006 Mar; 6(1):19-23. PubMed ID: 17138391
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FDA notifications. FDA approves new Kaletra formulation.
    AIDS Alert; 2005 Dec; 20(12):142-3. PubMed ID: 16400722
    [No Abstract]   [Full Text] [Related]  

  • 44. Safety and efficacy of the CYPHER Select Sirolimus-eluting stent in the "Real World"--clinical and angiographic results from the China CYPHER Select registry.
    Gao RL; Xu B; Lu SZ; Chen JL; Han YL; Chen JZ; Gai LY; Ge JB; Wang WM; Du ZM; Huo Y; Wang LF; Gao W; Chen JY; He B; Jia GL; Yang ZJ; Cao KJ; Li WM; Shen WF; Wan Z; Huang DJ; Zhu GY;
    Int J Cardiol; 2008 Apr; 125(3):339-46. PubMed ID: 17434617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evolving standard in the treatment of coronary artery disease. Drug-eluting stents.
    Sheiban I; Moretti C; Oliaro E; Catuzzo B; Destefanis P; Carrieri L; Sciuto F; Grosso Marra W; Omedè PL; Gagnor A; Truffa A; Trevi GP
    Minerva Cardioangiol; 2003 Oct; 51(5):485-92. PubMed ID: 14551518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thrombosis and drug-eluting stents: a critical appraisal.
    Kereiakes DJ; Choo JK; Young JJ; Broderick TM
    Rev Cardiovasc Med; 2004; 5(1):9-15. PubMed ID: 15029110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelial progenitor cell (EPC) capture to aid vascular repair following coronary stenting: a new frontier in stent technology?
    Houtgraaf JH; Duckers HJ
    EuroIntervention; 2008 Aug; 4 Suppl C():C67-71. PubMed ID: 19202700
    [No Abstract]   [Full Text] [Related]  

  • 48. Malfunctions and adverse events associated with off-label use of biliary stents in the peripheral vasculature.
    Bridges J; Maisel WH
    Am J Ther; 2008; 15(1):12-8. PubMed ID: 18223348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FDA notifications. FDA approves generic stavudine.
    AIDS Alert; 2009 Mar; 24(3):34. PubMed ID: 19441156
    [No Abstract]   [Full Text] [Related]  

  • 50. FDA notifications. FDA tentatively approves generic lamivudine.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17580368
    [No Abstract]   [Full Text] [Related]  

  • 51. Incidence of thrombosis after implantation of drug-eluting stents in patients with coronary artery disease.
    Chen JL; Yang YJ; Gao LJ; Huang JH; Qin XW; Qiao SB; Xu B; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL
    Chin Med J (Engl); 2008 Nov; 121(21):2144-7. PubMed ID: 19080174
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design.
    Pfisterer M; Bertel O; Bonetti PO; Brunner-La Rocca HP; Eberli FR; Erne P; Galatius S; Hornig B; Kiowski W; Pachinger O; Pedrazzini G; Rickli H; De Servi S; Kaiser C;
    Am Heart J; 2008 Apr; 155(4):609-14. PubMed ID: 18371466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FDA notifications. FDA approves half-strength Kaletra.
    AIDS Alert; 2008 Jan; 23(1):10. PubMed ID: 18572474
    [No Abstract]   [Full Text] [Related]  

  • 54. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
    Sabaté M; Jiménez-Quevedo P; Angiolillo DJ; Gómez-Hospital JA; Alfonso F; Hernández-Antolín R; Goicolea J; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
    Circulation; 2005 Oct; 112(14):2175-83. PubMed ID: 16203930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FDA notifications. FDA approves generic AZT.
    AIDS Alert; 2007 Jul; 22(7):79. PubMed ID: 17763553
    [No Abstract]   [Full Text] [Related]  

  • 56. Revascularization of diabetic patients: are drug-eluting stents the solution?
    Guagliumi G; Musumeci G
    Ital Heart J; 2005 Jun; 6(6):507-13. PubMed ID: 16008156
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FDA notifications. FDA approves generic lamivudine.
    AIDS Alert; 2008 Dec; 23(12):142. PubMed ID: 19110688
    [No Abstract]   [Full Text] [Related]  

  • 58. Adjusted indirect comparison of intracoronary drug-eluting stents: evidence from a metaanalysis of randomized bare-metal-stent-controlled trials.
    Biondi-Zoccai GG; Agostoni P; Abbate A; Testa L; Burzotta F; Lotrionte M; Crea F; Biasucci LM; Vetrovec GW; Colombo A
    Int J Cardiol; 2005 Apr; 100(1):119-23. PubMed ID: 15820294
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FDA approves meat irradiation for pathogen control.
    Public Health Rep; 1998; 113(2):105. PubMed ID: 9719806
    [No Abstract]   [Full Text] [Related]  

  • 60. FDA approves three imaging agents and considers two other agents and the gastric emptying petition.
    Tilyou SM
    J Nucl Med; 1990 Feb; 31(2):13A-14A, 19A. PubMed ID: 2313351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.